Atorvastatin calcium and Walking disability - a phase IV clinical study of FDA data

Summary:

Walking disability is reported as a side effect among people who take Atorvastatin calcium (atorvastatin calcium), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Amlodipine, and have Quit smoking.

The phase IV clinical study analyzes which people have Walking disability when taking Atorvastatin calcium. It is created by eHealthMe based on reports of 72,753 people who have side effects when taking Atorvastatin calcium from the FDA, and is updated regularly.

What is Atorvastatin calcium?

Atorvastatin calcium has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 77,310 Atorvastatin calcium users. Check the latest studies of Atorvastatin calcium.

What is Walking disability?

Walking disability is found to be associated with 290 drugs and 814 conditions by eHealthMe. Check the latest studies of Walking disability.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 15, 2026

72,753 people reported to have side effects when taking Atorvastatin calcium.
Among them, 12 people (0.02%) have Walking disability.

Could Atorvastatin calcium cause Walking disability?

Among these 12 people:

How long have people been on Atorvastatin calcium when they have Walking disability? *

What is the gender of people who have Walking disability when taking Atorvastatin calcium? *

female: 75 %
male: 25 %

What is the age of people who have Walking disability when taking Atorvastatin calcium? *

What are other drugs people take besides Atorvastatin calcium? *

What are other side effects people have besides Walking disability? *

Weakness: 6 people, 50.00%
Fall: 4 people, 33.33%
Dizziness: 4 people, 33.33%
Fatigue (feeling of tiredness): 3 people, 25.00%
Insomnia (sleeplessness): 3 people, 25.00%
Abdominal Pain: 2 people, 16.67%
Carpal Tunnel Syndrome (nerve compression at wrist results numbness weakness, pain , swelling): 2 people, 16.67%
Feeling Abnormal: 2 people, 16.67%
Head Discomfort: 2 people, 16.67%
Joint Pain: 2 people, 16.67%

What are the existing conditions these people have? *

Quit Smoking: 2 people, 16.67%
Type 2 Diabetes: 1 person, 8.33%
Neuralgia (pain in one or more nerves): 1 person, 8.33%
Coronary Heart Disease (narrowing or blockage of the coronary arteries): 1 person, 8.33%
Burning Sensation: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Atorvastatin calcium and have Walking disability?

- Check whether Walking disability is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atorvastatin calcium:

Atorvastatin calcium (77,310 reports)

Browse all side effects of Atorvastatin calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Walking disability:

Walking disability (290 drugs)

Browse all the conditions that are associated with Walking disability:

Walking disability (814 conditions)

Related publications that referenced our studies

Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .
Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on atorvastatin calcium (the active ingredients of Atorvastatin calcium) and Atorvastatin calcium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.